Creating rapid, sustainable and scalable technologies for protein and nucleic acid purification.
At Entropix Ltd, we are developing groundbreaking technologies for the purification of proteins and nucleic acids (DNA and RNA). We also have extensive expertise in the development of high performance enzymes and biocatalysts.
Our mission is to deliver next-generation solutions that drive efficiency, precision and scalability in nucleic acid and protein purification, laying the foundation for breakthroughs in proteomics, genomics and beyond.
Whether you’re extracting high-integrity nucleic acids or isolating complex protein mixtures, our platform solutions are engineered to meet the exacting demands of modern life science research, clinical diagnostics, and biopharmaceutical development. With innovation rooted in deep scientific insight, Entropix empowers researchers to:
NADA™ – Rapid Nucleic Acid Purification Without Compromise
From DNA to RNA, our novel extraction and purification chemistries and platforms are built to ensure high-quality nucleic acids suitable for sensitive applications like qPCR, NGS, and transcriptomics in a fraction of the time of current methods.
Learn more about NADA™ technology for nucleic acid purification.
SCOPE™ – Precision Tools for Proteomic Insight
Our purification technologies are tailored for proteomics, where sample quality directly impacts data fidelity. Entropix delivers rapid, reproducible workflows designed to preserve protein integrity and enable accurate downstream analysis—from mass spectrometry to structural biology. Our protein purification technology also has potential applications in larger-scale industrial processes such as plant protein production.
Learn more about our SCOPE™ technology for proteins.
Enzyme Development
Using Directed Evolution, we are developing a portfolio of proteins with performance characteristics encoded to transform many aspects of medicine manufacturing and recycling. We believe that enzymes will play a major role in delivering a truly sustainable economy.
Entropix is part of this revolution.
Following the recent publication of our patent, we’re proud to share further insights into our innovative ‘NADA’ technology. This first academic publication exploring NADA’s application
Introduction Daresbury Proteins Ltd specializes in the development and manufacture of complex recombinant proteins for a range of therapeutic and research applications expressed in mammalian
Introduction Professor Simon Foster’s laboratory carries out pioneering research in the field of antibiotic resistance research. Uncovering the role of genomic elements in the resistance